Turn this role into an interview — a resume and cover letter built around what this employer wants.
Outlook Therapeutics Inc. is seeking an FP&A Manager to partner with Corporate G&A, Tech Ops, and Medical leaders, owning planning, spend management, and reporting during a pivotal product launch.
You will build financial models, track headcount and vendor commitments, and deliver insights to executives to guide strategic decisions. This remote US-based role reports to the Senior Director, Commercial Finance and offers growth in a commercialization phase.
Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. In the United States, our lead product has received FDA approval, making it the first and only FDA-approved ophthalmic formulation of its kind for the treatment of wet AMD, and we are preparing for US commercial launch. Our lead product is also the first ophthalmic formulation of its kind to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and has launched across Germany, Austria, and the UK. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.
Reports To – Senior Director, Commercial Finance
Level – Manager
Location – Remote (US-based)
Employment Type – Full-time
Direct Reports: No
This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.
As FP&A Manager, you will be a key finance business partner to Corporate G&A, Tech Ops, and Medical leaders, supporting the financial management and growth of Outlook Therapeutics during an active product launch — owning financial planning and analysis, expense management, management reporting, and the financial insights that drive strategic and operational decisions.
Expense Management & Reporting
Business Development Support
Required
Preferred
In keeping with our commitment to pay transparency, the good-faith base salary range for this role is $110,000-$145,000, with an annual target bonus of 15%. This role is also eligible for a meaningful equity grant, reflecting the opportunity to build lasting value at a company at a commercial inflection point. Final compensation reflects experience, skills, and location.
Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.